XML 38 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based payments
12 Months Ended
Jan. 31, 2025
Share-based payments  
Share-based payments

9.Share-based payments

The Company accounts for share-based payments in accordance with applicable accounting standards, under which the fair value of each award is separately estimated and amortized into compensation expense over the service period. The fair value of the Company’s stock option grants are estimated on the grant date using the Black-Scholes-Merton valuation model. The application of this valuation model involves assumptions that are judgmental and highly sensitive in the determination of compensation expense. The fair value of the Company’s other share-based awards discussed below are estimated using the Company’s closing stock price on the grant date. Forfeitures are estimated at the time of valuation and reduce expense ratably over the vesting period.

On May 26, 2021, the Company’s shareholders approved the Dollar General Corporation 2021 Stock Incentive Plan (“2021 Plan”), which replaced the Company’s 2007 Stock Incentive Plan (“2007 Plan”). The Plans

allow the granting of stock options, stock appreciation rights, and other stock-based awards or dividend equivalent rights to key employees, directors, consultants or other persons having a service relationship with the Company, its subsidiaries and certain of its affiliates. Upon the effective date of the 2021 Plan, no new awards may be granted under the 2007 Plan. Awards previously granted under the 2007 Plan remain outstanding in accordance with their terms. The number of shares of Company common stock authorized for grant under the 2021 Plan is 11,838,143.

Generally, share-based awards issued by the Company are in the form of stock options, restricted stock units and performance share units, and unless noted otherwise, the disclosures that follow refer to such awards. With limited exceptions, stock options and restricted stock units granted to employees generally vest ratably on an annual basis over four-year and three-year periods, respectively. Awards granted to board members generally vest over a one-year period. The number of performance share units earned are based on performance criteria measured over a period of one to three years, and such awards generally vest over a three-year period. With limited exceptions, the performance share unit and restricted stock unit awards are payable in shares of common stock on the vesting date.

The weighted average for key assumptions used in determining the fair value of all stock options granted in the years ended January 31, 2025, February 2, 2024, and February 3, 2023, and a summary of the methodology applied to develop each assumption, are as follows:

    

January 31,

    

February 2,

    

February 3,

 

2025

2024

2023

 

Expected dividend yield

 

1.6

%  

1.5

%  

1.0

%

Expected stock price volatility

 

30.4

%  

27.7

%  

25.4

%

Weighted average risk-free interest rate

 

4.1

%  

4.1

%  

2.4

%

Expected term of options (years)

 

4.7

4.7

4.8

Expected dividend yield - This is an estimate of the expected dividend yield on the Company’s stock. An increase in the dividend yield will decrease compensation expense.

Expected stock price volatility - This is a measure of the amount by which the price of the Company’s common stock has fluctuated or is expected to fluctuate, calculated based upon historical volatility. An increase in the expected volatility will increase compensation expense.

Weighted average risk-free interest rate - This is the U.S. Treasury rate for the week of the grant having a term approximating the expected life of the option. An increase in the risk-free interest rate will increase compensation expense.

Expected term of options - This is the period of time over which the options granted are expected to remain outstanding. An increase in the expected term will increase compensation expense.

A summary of the Company’s stock option activity during the year ended January 31, 2025 is as follows:

    

    

Average

    

Remaining

    

 

Options

Exercise

Contractual

Intrinsic

 

(Intrinsic value amounts reflected in thousands)

Issued

Price

Term in Years

Value

 

Balance, February 2, 2024

 

2,413,642

$

164.21

Granted

 

891,666

 

148.85

Exercised

 

(101,719)

 

100.04

Canceled or expired

 

(243,651)

 

178.65

Balance, January 31, 2025

 

2,959,938

$

160.60

 

6.7

$

28,020

Exercisable at January 31, 2025

 

1,366,006

$

159.59

 

4.6

$

28,020

The weighted average grant date fair value per share of options granted was $42.06, $44.97 and $52.06 during 2024, 2023 and 2022, respectively. The intrinsic value of options exercised during 2024, 2023 and 2022, was $4.8 million, $19.0 million and $62.7 million, respectively.

The number of performance share unit awards earned is based upon the Company’s financial performance as specified in the award agreement. A summary of performance share unit award activity during the year ended January 31, 2025 is as follows:

    

Units

    

Intrinsic

 

(Intrinsic value amounts reflected in thousands)

Issued

Value

 

Balance, February 2, 2024

 

174,160

Granted

 

70,010

Converted to common stock

 

(115,251)

Canceled

 

(57,189)

Balance, January 31, 2025

 

71,730

$

5,097

All performance share unit awards at January 31, 2025 are unvested, and the number of such awards which will ultimately vest will be based in part on the Company’s financial performance in future years. The weighted average grant date fair value per share of performance share units granted was $154.21, $208.13 and $214.25 during 2024, 2023 and 2022, respectively.

A summary of restricted stock unit award activity during the year ended January 31, 2025 is as follows:

    

Units

    

Intrinsic

 

(Intrinsic value amounts reflected in thousands)

Issued

Value

 

Balance, February 2, 2024

 

370,463

Granted

 

507,975

Converted to common stock

 

(144,713)

Canceled

 

(91,765)

Balance, January 31, 2025

 

641,960

$

45,618

The weighted average grant date fair value per share of restricted stock units granted was $130.78, $193.78 and $223.51 during 2024, 2023 and 2022, respectively.

At January 31, 2025, the total unrecognized compensation cost related to unvested stock-based awards was $85.5 million with an expected weighted average expense recognition period of 1.9 years.

The fair value method of accounting for share-based awards resulted in share-based compensation expense (a component of SG&A expenses) and a corresponding reduction in income before and net of income taxes as follows:

Stock

Performance

Restricted

 

(In thousands)

    

Options

    

Share Units

    

Stock Units

    

Total

 

Year ended January 31, 2025

Pre-tax

$

21,137

$

970

$

36,631

$

58,738

Net of tax

$

16,529

$

759

$

28,645

$

45,933

Year ended February 2, 2024

Pre-tax

$

19,400

$

1,732

$

30,759

$

51,891

Net of tax

$

15,210

$

1,358

$

24,115

$

40,683

Year ended February 3, 2023

Pre-tax

$

20,502

$

26,920

$

25,249

$

72,671

Net of tax

$

15,893

$

20,868

$

19,573

$

56,334